Reposted by Sean James Fallon
Results from a large clinical trial, from IoPPN, @nihrmaudsleybrc.bsky.social, @unisouthampton.bsky.social, finds a trigeminal nerve stimulation device approved by the US FDA in 2019, is not an effective tool in reducing symptoms of #ADHD
Read the full story:
www.kcl.ac.uk/news/title-b...
kcl.ac.uk
Brain stimulation device cleared for ADHD in the US is overall safe but ineffective | King's College London
A large multicentre clinical trial led by King’s College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms.